Human Cutaneous Leishmaniosis in Iran, Up to Date-2019

Cutaneous leishmaniasis is a neglected and parasitic vector borne diseases that is endemic in tropical and subtropical countries, including Iran. The aim of this study was to explain the present status of CL in Iran. This report is based on data that recorded by cutaneous leishmaniasis surveillance...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Mohamad Reza Razavi, Mohammad Reza Shirzadi, Mehdi Mohebali, Mohammad Reza Yaghoobi-Ershadi, Hassan Vatandoost, Mehrshad Shirzadi, Mohammad Mehdi Gouya, Faranak Gharachorloo, Shahnam Arshi, Behzad Amiri
Formato:	article
Lenguaje:	EN
Publicado:	Tehran University of Medical Sciences 2022
Materias:	Human cutaneous leishmaniasis; Surveillance; Iran Pathology RB1-214
Acceso en línea:	https://doaj.org/article/bcc87a20cfac4386a57337efc882a2d5
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:bcc87a20cfac4386a57337efc882a2d5
record_format	dspace
spelling	oai:doaj.org-article:bcc87a20cfac4386a57337efc882a2d52021-12-02T18:22:09ZHuman Cutaneous Leishmaniosis in Iran, Up to Date-201910.18502/jad.v15i2.74831735-71792322-2271https://doaj.org/article/bcc87a20cfac4386a57337efc882a2d52022-01-01T00:00:00Zhttps://jad.tums.ac.ir/index.php/jad/article/view/1494https://doaj.org/toc/1735-7179https://doaj.org/toc/2322-2271 Cutaneous leishmaniasis is a neglected and parasitic vector borne diseases that is endemic in tropical and subtropical countries, including Iran. The aim of this study was to explain the present status of CL in Iran. This report is based on data that recorded by cutaneous leishmaniasis surveillance system in 2019, and evaluated in Center for Communicable Diseases Management in Ministry of Health in Iran. Iran has been considered an endemic area for cutaneous leishmaniasis in the world. Dependent to activities for cutaneous leishmaniasis control the number of cases decreased from 23202 in 2008 (Incidence rate 32 per 100000) to 13124 in 2019 (Incidence rate 15.8 per 100000), more cases reported from September to December, in 2019, 46% of cases had one lesion and 21% had 2 lesions, 85% of cases diagnosed when the diameter of lesions had 3 centimeters and bellows. Although the Leishmania control program began in 1977, the incidence of the disease has dropped dramatically since 2008 when the new cutaneous leishmaniasis control program have been implemented. Although in some areas the incidence of the disease increased, but the implementation of the new program has reduced the number of cases, in order to continue reducing the disease, permanent support for the control programs is needed. Mohamad Reza RazaviMohammad Reza ShirzadiMehdi MohebaliMohammad Reza Yaghoobi-ErshadiHassan VatandoostMehrshad ShirzadiMohammad Mehdi GouyaFaranak GharachorlooShahnam ArshiBehzad AmiriTehran University of Medical SciencesarticleHuman cutaneous leishmaniasis; Surveillance; IranPathologyRB1-214ENJournal of Arthropod-Borne Diseases , Vol 15, Iss 2 (2022)
institution	DOAJ
collection	DOAJ
language	EN
topic	Human cutaneous leishmaniasis; Surveillance; Iran Pathology RB1-214
spellingShingle	Human cutaneous leishmaniasis; Surveillance; Iran Pathology RB1-214 Mohamad Reza Razavi Mohammad Reza Shirzadi Mehdi Mohebali Mohammad Reza Yaghoobi-Ershadi Hassan Vatandoost Mehrshad Shirzadi Mohammad Mehdi Gouya Faranak Gharachorloo Shahnam Arshi Behzad Amiri Human Cutaneous Leishmaniosis in Iran, Up to Date-2019
description	Cutaneous leishmaniasis is a neglected and parasitic vector borne diseases that is endemic in tropical and subtropical countries, including Iran. The aim of this study was to explain the present status of CL in Iran. This report is based on data that recorded by cutaneous leishmaniasis surveillance system in 2019, and evaluated in Center for Communicable Diseases Management in Ministry of Health in Iran. Iran has been considered an endemic area for cutaneous leishmaniasis in the world. Dependent to activities for cutaneous leishmaniasis control the number of cases decreased from 23202 in 2008 (Incidence rate 32 per 100000) to 13124 in 2019 (Incidence rate 15.8 per 100000), more cases reported from September to December, in 2019, 46% of cases had one lesion and 21% had 2 lesions, 85% of cases diagnosed when the diameter of lesions had 3 centimeters and bellows. Although the Leishmania control program began in 1977, the incidence of the disease has dropped dramatically since 2008 when the new cutaneous leishmaniasis control program have been implemented. Although in some areas the incidence of the disease increased, but the implementation of the new program has reduced the number of cases, in order to continue reducing the disease, permanent support for the control programs is needed.
format	article
author	Mohamad Reza Razavi Mohammad Reza Shirzadi Mehdi Mohebali Mohammad Reza Yaghoobi-Ershadi Hassan Vatandoost Mehrshad Shirzadi Mohammad Mehdi Gouya Faranak Gharachorloo Shahnam Arshi Behzad Amiri
author_facet	Mohamad Reza Razavi Mohammad Reza Shirzadi Mehdi Mohebali Mohammad Reza Yaghoobi-Ershadi Hassan Vatandoost Mehrshad Shirzadi Mohammad Mehdi Gouya Faranak Gharachorloo Shahnam Arshi Behzad Amiri
author_sort	Mohamad Reza Razavi
title	Human Cutaneous Leishmaniosis in Iran, Up to Date-2019
title_short	Human Cutaneous Leishmaniosis in Iran, Up to Date-2019
title_full	Human Cutaneous Leishmaniosis in Iran, Up to Date-2019
title_fullStr	Human Cutaneous Leishmaniosis in Iran, Up to Date-2019
title_full_unstemmed	Human Cutaneous Leishmaniosis in Iran, Up to Date-2019
title_sort	human cutaneous leishmaniosis in iran, up to date-2019
publisher	Tehran University of Medical Sciences
publishDate	2022
url	https://doaj.org/article/bcc87a20cfac4386a57337efc882a2d5
work_keys_str_mv	AT mohamadrezarazavi humancutaneousleishmaniosisiniranuptodate2019 AT mohammadrezashirzadi humancutaneousleishmaniosisiniranuptodate2019 AT mehdimohebali humancutaneousleishmaniosisiniranuptodate2019 AT mohammadrezayaghoobiershadi humancutaneousleishmaniosisiniranuptodate2019 AT hassanvatandoost humancutaneousleishmaniosisiniranuptodate2019 AT mehrshadshirzadi humancutaneousleishmaniosisiniranuptodate2019 AT mohammadmehdigouya humancutaneousleishmaniosisiniranuptodate2019 AT faranakgharachorloo humancutaneousleishmaniosisiniranuptodate2019 AT shahnamarshi humancutaneousleishmaniosisiniranuptodate2019 AT behzadamiri humancutaneousleishmaniosisiniranuptodate2019
_version_	1718378180236017664

Human Cutaneous Leishmaniosis in Iran, Up to Date-2019

Ejemplares similares